BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18068866)

  • 1. Hematopoietic cell transplantation for hemoglobinopathies.
    Krishnamurti L; Bunn HF; Williams AM; Tolar J
    Curr Probl Pediatr Adolesc Health Care; 2008 Jan; 38(1):6-18. PubMed ID: 18068866
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience.
    Zaidman I; Rowe JM; Khalil A; Ben-Arush M; Elhasid R
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1043-1048. PubMed ID: 27016193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Era for Hemoglobinopathies: More Than One Curative Option.
    Psatha N; Papayanni PG; Yannaki E
    Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy for Hemoglobinopathies: Beta-Thalassemia, Sickle Cell Disease.
    Leonard A; Tisdale JF; Bonner M
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):769-795. PubMed ID: 35773052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy.
    Hayashi S; Abdulmalik O; Peranteau WH; Ashizuka S; Campagnoli C; Chen Q; Horiuchi K; Asakura T; Flake AW
    Exp Hematol; 2003 Feb; 31(2):176-84. PubMed ID: 12591283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic Stem Cell Transplantation in Patients with Hemoglobinopathies.
    Yesilipek MA
    Hemoglobin; 2020 Nov; 44(6):377-384. PubMed ID: 33050763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
    Al Jefri AH
    Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
    Payen E; Leboulch P
    Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy for Hemoglobinopathies.
    Lidonnici MR; Scaramuzza S; Ferrari G
    Hum Gene Ther; 2023 Sep; 34(17-18):793-807. PubMed ID: 37675899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Therapy for β-Hemoglobinopathies: From Discovery to Clinical Trials.
    Segura EER; Ayoub PG; Hart KL; Kohn DB
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing for the β-Hemoglobinopathies.
    Porteus MH
    Adv Exp Med Biol; 2017; 1013():203-217. PubMed ID: 29127682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassemia and related hemoglobinopathies.
    Sarnaik SA
    Indian J Pediatr; 2005 Apr; 72(4):319-24. PubMed ID: 15876761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.
    Andreani M; Testi M; Gaziev J; Condello R; Bontadini A; Tazzari PL; Ricci F; De Felice L; Agostini F; Fraboni D; Ferrari G; Battarra M; Troiano M; Sodani P; Lucarelli G
    Haematologica; 2011 Jan; 96(1):128-33. PubMed ID: 20935000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies.
    Kharya G; Bakane AN; Rauthan AM
    Pediatr Blood Cancer; 2021 Apr; 68(4):e28909. PubMed ID: 33470527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero transplantation for thalassemia.
    Flake AW; Zanjani ED
    Ann N Y Acad Sci; 1998 Jun; 850():300-11. PubMed ID: 9668552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
    Horan JT; Liesveld JL; Fenton P; Blumberg N; Walters MC
    Bone Marrow Transplant; 2005 Jan; 35(2):171-7. PubMed ID: 15531901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
    Bernaudin F; Pondarré C; Galambrun C; Thuret I
    Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.